Research news
Surprising finding in rare form of melanoma get patients closer to personalised medicine
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Using new technology to prevent melanoma
Innovation is helping to prevent melanoma developing in the first place.
Research review of 2017
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
New research to guide clinicians to more accurately stage and manage melanoma patients
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Enhancing melanoma treatment response through gut bacteria
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
Comparing melanoma risk in similar populations across different latitudes
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
What causes melanoma in 90% of young Australians?
New research shows potentially deadly UV damage can appear decades earlier than you think.
Smoking linked to increased risk of melanoma spreading
New research has shown that melanoma patients who smoke have an increased risk of their disease progressing compared to patients who do not smoke.
Highlights in melanoma research from ESMO
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Virus-antibody combo shows promise for treating advanced melanoma
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.